Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibiotics
Biotech
Destiny ends COVID collab, Santhera returns lonodelestat
Both Destiny and Santhera explained why a tighter clinical focus comes at the expense of one of their potential assets
James Waldron
Apr 25, 2024 8:23am
GSK antibiotic shows potential in gonorrhea ahead of UTI filing
Feb 26, 2024 7:32am
Synthetic antibiotic kills multidrug-resistant pathogens in mice
Feb 16, 2024 7:00am
AN2's stock craters as lead lung disease phase 3 trial paused
Feb 12, 2024 8:16am
Roche designs new antibiotic to fight drug-resistant infections
Jan 3, 2024 11:03am
‘Explainable’ AI finds new antibiotics that stop MRSA in mice
Dec 20, 2023 4:25pm